# Safety & Efficacy of Extended Longevity Protocol

> **NCT05296993** · PHASE2 · UNKNOWN · sponsor: **TruDiagnostic** · enrollment: 15 (estimated)

## Conditions studied

- Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Extracts found in the Extended Longevity supplements

## Key facts

- **NCT ID:** NCT05296993
- **Lead sponsor:** TruDiagnostic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-25
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05296993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05296993, "Safety & Efficacy of Extended Longevity Protocol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05296993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*